August 27, 2021
Gibson, Dunn & Crutcher LLP is advising StriVectin and L Catterton in in the sale of StriVectin to Crown Laboratories, a Hildred Capital Management LLC portfolio company. More information can be found in the announcement release.
The Gibson Dunn corporate team is led by partner Steven Shoemate and includes associate Phillip Sanders. Partner Darius Mehraban is advising on financing. Partner Kathryn Kelly is advising on tax aspects, and partner Michael Collins is advising on benefits.